...

首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Does the Use of Tamoxifen during Controlled Ovarian Hyperstimulation Alter Estrogen Metabolism Favoring a Protective Effect On Breast Cancer Risk?

【24h】

Does the Use of Tamoxifen during Controlled Ovarian Hyperstimulation Alter Estrogen Metabolism Favoring a Protective Effect On Breast Cancer Risk?

机译：在控制性卵巢过度刺激过程中使用他莫昔芬是否会改变雌激素代谢，从而有利于保护乳腺癌风险？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society》 |2013年第3suppla期|共2页
作者
Gualtieri M.; Lee F.; Stanczyk F.; Patel S.; Bendikson K.; Paulson R.; Chung K.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇科学;
关键词

相似文献

外文文献
中文文献
专利

1. Does the Use of Tamoxifen during Controlled Ovarian Hyperstimulation Alter Estrogen Metabolism Favoring a Protective Effect On Breast Cancer Risk? [J] . Gualtieri M., Lee F., Stanczyk F., Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society . 2013,第3Suppla期

机译：在控制性卵巢过度刺激过程中使用他莫昔芬是否会改变雌激素代谢，从而有利于保护乳腺癌风险？
2. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS) [J] . Fourkala Evangelia-Ourania, Blyuss Oleg, Field Helen, Steroids: An International Journal . 2016,第Null期

机译：使用质谱和敏感提取物放射免疫测定法进行性激素测量以及雌激素受体阴性和阳性乳腺癌的风险：英国卵巢癌筛查合作癌症试验（UKCTOCS）中的病例对照研究
3. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS) (vol 110, pg 62, 2016) [J] . Fourkala Evangelia-Ourania, Blyuss Oleg, Field Helen, Steroids: An International Journal . 2016,第Null期

机译：使用质谱和敏感提取物放射免疫测定进行性激素测量以及雌激素受体阴性和阳性乳腺癌的风险：英国卵巢癌筛查合作癌症试验（UKCTOCS）中的病例对照研究（第110卷，第62页，2016年）
4. Study on Molecular Docking of Red Betel (Piper Crocatum Ruiz Pav.) Active Compound and Tamoxifen Drug as an Inhibitor of Estrogen Receptor-α (ER-α) that Plays a Role in Breast Cancer [C] . Siti Imroatul Maslikah, Sri Rahayu Lestari, Nursasi Handayani, International Conference on Life Sciences and Technology . 2020

机译：红色槟榔（吹笛茶叶ruiz＆pav.）活性化合物和三氧化物药物作为发挥乳腺癌作用的雌激素受体-α（ER-α）抑制剂的研究
5. Association of estrogen metabolism and risk of breast or prostate cancer or non-Hodgkin lymphoma: Detection of novel biomarkers from case-control studies. [D] . Yang, Li. 2010

机译：雌激素代谢与乳腺癌或前列腺癌或非霍奇金淋巴瘤风险的关联：病例对照研究中发现的新型生物标志物。
6. Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers [O] . Oranite Goldrat, Geraldine Van Den Steen, Eric Gonzalez-Merino, 2019

机译：乳腺癌患者中与来曲唑相关的控制性卵巢过度刺激与不育患者中传统的控制性卵巢过度刺激：与卵母细胞质量相关的生物标记物的评估
7. A prospective case series of women with estrogen receptor-positive breast cancer: levels of tamoxifen metabolites in controlled ovarian stimulation with high-dose tamoxifen [O] . E. M. E. Balkenende, T. Dahhan, S. C. Linn, 2013

机译：雌激素受体阳性乳腺癌的潜在病例系列妇女：高剂量Tamoxifen控制卵巢刺激中的三莫莫芬代代谢水平

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号